Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Hartmann

Showing results (151-160 of 265) with videos related to

Pageof 27
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 20, 2009
Chemoradiotherapy of newly diagnosed glioblastoma with intensified temozolomideMarkus Weiler, Christian Hartmann, Dorothee Wiewrodt, et al.
Brain Pathology (Zurich, Switzerland)|November 12, 2009
Characterization of R132H mutation-specific IDH1 antibody binding in brain tumorsDavid Capper, Susanne Weissert, Jörg Balss, et al.
Scientific Reports|January 23, 2024
Task design for crowdsourced glioma cell annotation in microscopy imagesSvea Schwarze, Nadine S Schaadt, Viktor M G Sobotta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2011
Molecular markers in low-grade gliomas: predictive or prognostic?Christian Hartmann, Bettina Hentschel, Marcos Tatagiba, et al.
Cancers|March 25, 2022
Differences in the MRI Signature and ADC Values of Diffuse Midline Gliomas with H3 K27M Mutation Compared to Midline GlioblastomasPeter Raab, Rouzbeh Banan, Arash Akbarian, et al.
Pediatric Blood & Cancer|June 8, 2021
Evidence for a low-penetrant extended phenotype of rhabdoid tumor predisposition syndrome type 1 from a kindred with gain of SMARCB1 exon 6Uwe Kordes, Victor-Felix Mautner, Florian Oyen, et al.
Seminars in Cancer Biology|June 24, 2018
Molecular pathway activation - New type of biomarkers for tumor morphology and personalized selection of target drugsAnton Buzdin, Maxim Sorokin, Andrew Garazha, et al.
Brain : a Journal of Neurology|September 6, 2007
Long-term survival with glioblastoma multiformeDietmar Krex, Barbara Klink, Christian Hartmann, et al.
Journal of the National Cancer Institute|February 25, 2011
Differential retinoic acid signaling in tumors of long- and short-term glioblastoma survivorsSebastian Barbus, Björn Tews, Daniela Karra, et al.
Clinical Neuropathology|November 3, 2015
KINFix--A formalin-free non-commercial fixative optimized for histological, immunohistochemical and molecular analyses of neurosurgical tissue specimensHarald Stefanits, Michal Bienkowski, Markus Galanski, et al.
Pageof 27

Showing results (151-160 of 265) with videos related to

Sort By:
Pageof 27
International Journal of Radiation Oncology, Biology, Physics|October 20, 2009
Chemoradiotherapy of newly diagnosed glioblastoma with intensified temozolomideMarkus Weiler, Christian Hartmann, Dorothee Wiewrodt, et al.
Brain Pathology (Zurich, Switzerland)|November 12, 2009
Characterization of R132H mutation-specific IDH1 antibody binding in brain tumorsDavid Capper, Susanne Weissert, Jörg Balss, et al.
Scientific Reports|January 23, 2024
Task design for crowdsourced glioma cell annotation in microscopy imagesSvea Schwarze, Nadine S Schaadt, Viktor M G Sobotta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2011
Molecular markers in low-grade gliomas: predictive or prognostic?Christian Hartmann, Bettina Hentschel, Marcos Tatagiba, et al.
Cancers|March 25, 2022
Differences in the MRI Signature and ADC Values of Diffuse Midline Gliomas with H3 K27M Mutation Compared to Midline GlioblastomasPeter Raab, Rouzbeh Banan, Arash Akbarian, et al.
Pediatric Blood & Cancer|June 8, 2021
Evidence for a low-penetrant extended phenotype of rhabdoid tumor predisposition syndrome type 1 from a kindred with gain of SMARCB1 exon 6Uwe Kordes, Victor-Felix Mautner, Florian Oyen, et al.
Seminars in Cancer Biology|June 24, 2018
Molecular pathway activation - New type of biomarkers for tumor morphology and personalized selection of target drugsAnton Buzdin, Maxim Sorokin, Andrew Garazha, et al.
Brain : a Journal of Neurology|September 6, 2007
Long-term survival with glioblastoma multiformeDietmar Krex, Barbara Klink, Christian Hartmann, et al.
Journal of the National Cancer Institute|February 25, 2011
Differential retinoic acid signaling in tumors of long- and short-term glioblastoma survivorsSebastian Barbus, Björn Tews, Daniela Karra, et al.
Clinical Neuropathology|November 3, 2015
KINFix--A formalin-free non-commercial fixative optimized for histological, immunohistochemical and molecular analyses of neurosurgical tissue specimensHarald Stefanits, Michal Bienkowski, Markus Galanski, et al.
Pageof 27